|Day Low/High||103.40 / 104.17|
|52 Wk Low/High||81.22 / 114.26|
Monsanto's (MON) stock rating was increased to 'overweight' at JPMorgan on Wednesday morning.
CEO Werner Baumann increases sales and margin forecasts for pharmaceuticals and insists Monsanto deal will deliver growth and improved profit.
Doug Kass shares his thoughts on what goes on his best ideas list and what's still moving down.
Citigroup analysts say Monsanto (MON) was 'left with little choice' but to accept the Bayer (BAYRY) offer, mostly due to the time value of money.
Despite intense opposition from farm groups and skepticism from government enforcers, the merging crop technology giants say they expect to win approval by end of 2017.
Bayer's (BAYRY) $66 billion all-cash takeover of Monsanto (MON) is expected to generate push back from political and regulatory officials who claim it threatens competition in the farm supplier industry.
Another selloff on commodity markets on Wednesday contributed to stock losses throughout the day.
Stocks lose highs by mid-afternoon Wednesday as a selloff in crude resumes.
Here's a technical look at how to trade some of the most active stocks on the market right now.
Jim Cramer says he doesn't think Bayer's proposed acquisition of Monsanto will close.
Bernstein analysts say Monsanto's (MON) $66 billion merger with Bayer (BAYRY) is up against steep antitrust hurdles, resulting in a 50% chance of it being completed.
The CEOs of Monsanto (MON) and Bayer (BAYRY) joined BloombergTV to discuss their $66 billion combination.
Stocks add to slight gains on Wednesday as Wall Street stabilizes after three days of extreme swings.
U.S. stocks gained steam on Wednesday, even though oil prices continued to slide.
Bloomberg Executive editor of global deals Jeff McCracken reacts to the deal in which Bayer (BAYRY) will acquire Monsanto (MON) for $66 billion, or $128 per share.
Stock futures edge higher on Wednesday as Wall Street appears to stabilize after three days of extreme swings.
The agreement values the world's biggest seed maker at $128 per share and comes with a promise of $1.5 billion of annual synergies.
Bayer has agreed to purchase Monsanto for $66 billion, or $128 a share, a 20% premium over its previous closing price.
Monsanto (MON) agreed to be purchased by Bayer (BAYRY) for $66 billion, or $128 per share, in an all-cash deal.
U.S. stock futures point to a slight rebound for Wall Street on Wednesday; report says Bayer to announce acquisition of Monsanto; Wells Fargo CEO John Stumpf says he won't resign.
Monsanto shares should rise if the $129-per-share deal, including a massive break fee, is confirmed, while Bayer investors appear unsure whether to celebrate or mourn.
Futures point toward a higher open Wednesday after strong drops Tuesday amid rate jitters and lower oil.
Bayer is upping its bid for Monsanto (MON), this time to $129 per share, according to Bloomberg.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: NILE, NL, UGP, YUME Downgrades: AIRT, ASM, BFS, ETP, FNV, GCAP, JNP, MON, TEDU Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
Monsanto's (MON) board could decide on the proposed acquisition by Bayer (BAYRY) today, sources told Reuters.
A deal between Bayer (BAYRY) and Monsanto (MON) could be announced next week, BloombergTV reports.
Bayer increases its latest offer to buy Monsanto, as regulators look closely at agribusiness mergers.
Bayer increases its latest offering to entice Monsanto, as regulators look closely at agribusiness mergers.